Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy clinical trial (NCT05451719). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the combination of fruquintinib and capecitabine compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy clinical trial (NCT05451719). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy clinical trial (NCT05451719). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits and treatments if I join this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy clinical trial (NCT05451719). Contact the study team or your healthcare provider for specific answers.

Question 5

What will happen if my cancer progresses while I am in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy clinical trial (NCT05451719). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any additional tests or procedures I would need to undergo if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy clinical trial (NCT05451719). Contact the study team or your healthcare provider for specific answers.

What this study is about